Cargando…

A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England

BACKGROUND: There is uncertainty about overdiagnosis in mammography screening. METHODS: We aimed to estimate the effect of screening on breast cancer incidence and overdiagnosis in the NHS Breast Screening Programme in England. The study included 57,493 cases and 105,653 controls, with cases defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blyuss, Oleg, Dibden, Amanda, Massat, Nathalie J., Parmar, Dharmishta, Cuzick, Jack, Duffy, Stephen W., Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883434/ https://www.ncbi.nlm.nih.gov/pubmed/35851849 http://dx.doi.org/10.1002/cam4.5004

Ejemplares similares

A case-control study to evaluate the impact of the breast screening programme on mortality in England
por: Maroni, Roberta, et al.
Publicado: (2020)

An ongoing case-control study to evaluate the NHS breast screening programme
por: Massat, Nathalie J, et al.
Publicado: (2013)

An ongoing case–control study to evaluate the NHS Bowel Cancer Screening Programme
por: Massat, Nathalie J, et al.
Publicado: (2014)

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022)

Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality
por: Dibden, Amanda, et al.
Publicado: (2020)

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
por: Duffy, Stephen W, et al.
Publicado: (2013)

Reply to Yaffe, M.J. Correction for Self-Selection in Breast Cancer Screening. Comment on “Dibden et al. Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality. Cancers 2020, 12, 976”
por: Dibden, Amanda, et al.
Publicado: (2023)

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
por: Duffy, Stephen W, et al.
Publicado: (2020)

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
por: Duffy, Stephen W, et al.
Publicado: (2016)

Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour
por: Massat, Nathalie J, et al.
Publicado: (2015)

A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales
por: Fielder, HM, et al.
Publicado: (2004)

Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis
por: Rebolj, Matejka, et al.
Publicado: (2018)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme
por: Dibden, A, et al.
Publicado: (2014)

Long-term excess risk of breast cancer after a single breast density measurement
por: Rebolj, Matejka, et al.
Publicado: (2019)

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
por: Duffy, Stephen W, et al.
Publicado: (2010)

Informed Decision-Making and Breast Cancer Screening
por: Sasieni, PD, et al.
Publicado: (2015)

Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths
por: Geurts, S M E, et al.
Publicado: (2015)

Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study
por: Li, Shuping J., et al.
Publicado: (2022)

Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies
por: Li, Shuping J, et al.
Publicado: (2020)

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review
por: Broeders, M. J. M., et al.
Publicado: (2018)

Breast clinicians: their contribution to the breast screening programme in England and implications of the current age structure
por: Swinson, C
Publicado: (2012)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap?
por: Douglas, Elaine, et al.
Publicado: (2015)

Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial
por: Laake, Jean-Pierre, et al.
Publicado: (2020)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

A case–control study of the impact of the East Anglian breast screening programme on breast cancer mortality
por: Allgood, P C, et al.
Publicado: (2008)

What should the detection rates of cancers be in breast screening programmes?
por: Duffy, S W, et al.
Publicado: (2005)

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland
por: Bennett, R L, et al.
Publicado: (2011)

The impact of COVID-19 on national screening programmes in England
por: Armitage, R.C., et al.
Publicado: (2021)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States
por: Landy, Rebecca, et al.
Publicado: (2019)

Reply: The value of case–control audits of screening
por: Sasieni, P, et al.
Publicado: (2004)

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
Publicado: (2010)

Interpreting the results of noninferiority trials—a review
por: Cuzick, Jack, et al.
Publicado: (2022)

Impact of preventive therapy on the risk of breast cancer among women with benign breast disease
por: Cuzick, Jack, et al.
Publicado: (2015)

Future possibilities in the prevention of breast cancer: Breast cancer prevention trials
por: Cuzick, Jack
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_kguk3kd11o811gvv8k3pkoua50